About the Authors
- Xiaoping Du
-
Affiliation Hough Ear Institute, Oklahoma City, Oklahoma, United States of America
- Donald L. Ewert
-
Affiliation Hough Ear Institute, Oklahoma City, Oklahoma, United States of America
- Weihua Cheng
-
Affiliation Hough Ear Institute, Oklahoma City, Oklahoma, United States of America
- Matthew B. West
-
Affiliation Hough Ear Institute, Oklahoma City, Oklahoma, United States of America
- Jianzhong Lu
-
Affiliation Hough Ear Institute, Oklahoma City, Oklahoma, United States of America
- Wei Li
-
Affiliation Hough Ear Institute, Oklahoma City, Oklahoma, United States of America
- Robert A. Floyd
-
Affiliation Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America
- Richard D. Kopke
-
* E-mail: rkopke@houghear.org
Affiliations Hough Ear Institute, Oklahoma City, Oklahoma, United States of America, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America, Departments of Physiology and Otolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
Competing Interests
Richard Kopke and Robert Floyd have a financial interest in Otologic Pharmaceutics Inc. which has a license for the development of HPN-07 for treatment of hearing loss and brain injury. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: XD DE RF RK. Performed the experiments: XD DE WC WL JL. Analyzed the data: XD DE RK. Wrote the manuscript: XD DE MW RF EK.